These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3518548)

  • 1. Platelet hyperaggregability, blood prostacyclin and dipyridamole.
    Solvay H; Kahn M; Cloarec M; Van De Merckt J; Sneppe R; Schram E; Fenollar JV
    Angiology; 1986 Mar; 37(3 Pt 1):175-84. PubMed ID: 3518548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
    Akopov SE; Gabrielian ES
    J Clin Pharmacol; 1993 Nov; 33(11):1048-51. PubMed ID: 8300887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose and erythrocyte ATP: distinctive effects of dipyridamole and of ticlopidine.
    Solvay H; Kahn M; Garreyn S; Cloarec M; Sneppe R; Schram E; Fenollar JV
    Angiology; 1987 Nov; 38(11):815-24. PubMed ID: 3688549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of ischemia and dipyridamole on prostacyclin production in arteriosclerosis obliterans.
    Viinikka L; Kärkölä P; Pokela R; Ylikorkala O
    Prostaglandins; 1981 May; 21(5):821-6. PubMed ID: 7041195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamole.
    Sinzinger H; O'Grady J; Fitscha P
    J Int Med Res; 1988; 16(1):39-43. PubMed ID: 3350203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous epoprostenol on platelets and the cardiovascular system are not potentiated by dipyridamole.
    Pickles H; Fish A; Hassan S; Burke C; Warrington S; O'Grady J
    Clin Pharmacol Ther; 1983 Feb; 33(2):178-82. PubMed ID: 6337004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium.
    Wautier JL; Pintigny D; Maclouf J; Wautier MP; Corvazier E; Caen J
    J Lab Clin Med; 1986 Mar; 107(3):210-5. PubMed ID: 3081670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prostacyclin production from human veins by dipyridamole: an in vitro and ex vivo study.
    Costantini V; Talpacci A; Bastiano ML; Boschetti E; Cipolloni S; Bisacci R; Nenci GG
    Biomed Biochim Acta; 1990; 49(4):263-71. PubMed ID: 2119575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the complex treatment of stable stenocardia on the status of the prostacyclin-thromboxane system].
    Khimenko PL
    Ter Arkh; 1986; 58(5):95-8. PubMed ID: 2874621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced prostacyclin production by dipyridamole in man.
    Neri Serneri GG; Masotti G; Poggesi L; Galanti G; Morettini A
    Eur J Clin Pharmacol; 1981; 21(1):9-15. PubMed ID: 7037426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous atherosclerotic lesions and prostacyclin formation in rabbits: effects of combined dipyridamole and aspirin.
    Lasierra J; Gonzalez J; Aza MJ; Melon J; Vazquez E; Collado PS; Castellarnau C; Rutllant M
    Biomed Biochim Acta; 1989; 48(9):721-5. PubMed ID: 2515856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the stimulation of human venous prostacyclin synthesis by dipyridamole.
    Jackson CA; Greaves M; Preston FE
    Thromb Res; 1982 Sep; 27(5):563-73. PubMed ID: 6758183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet microaggregates and release of endogenous prostacyclin during the initial phase of haemodialysis.
    Leithner C; Sinzinger H; Silberbauer K; Stummvoll HK
    Proc Eur Dial Transplant Assoc; 1981; 18():122-5. PubMed ID: 7036146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
    Bozzo J; Hernández MR; Ordinas A
    Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.